STUDY SEARCH RESULTS

1 study found for your search request:  7902-015

Efficacy and Safety of Lenvatinib (E7080/MK-7902) plus Pembrolizumab (MK-3475) plus Chemotherapy in ...
Condition: Advanced/Metastatic Gastroesophageal Adenocarcinoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04662710
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site